Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1962 USD | -3.82% | -17.95% | -84.28% |
Apr. 01 | CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 27 | CNS Pharmaceuticals, Inc. Approves the Appointments to its Board Committees | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-84.28% | 2.17M | |
-1.88% | 41.35B | |
+42.15% | 40.38B | |
+1.21% | 39.05B | |
-14.19% | 26.67B | |
+1.76% | 24.07B | |
-24.50% | 18.36B | |
-4.08% | 11.68B | |
+21.11% | 11.6B | |
+7.77% | 11.15B |
- Stock Market
- Equities
- CNSP Stock
- News CNS Pharmaceuticals, Inc.
- CNS Pharmaceuticals : Starts Dosing in Trial of Berubicin Chemotherapy for Brain Cancer